PSA, PSA derivatives, proPSA and prostate health index in the diagnosis of prostate cancer
Abstract Currently, prostate- specific antigen (PSA) is the most common oncological marker used for prostate cancer screening. However, high levels of PSA in benign prostatic hyperplasia and prostatitis decrease the specificity of PSA as a cancer marker. To increase the specificity of PSA, PSA deri...
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Turkish Association of Urology
2019-07-01
|
| Saila: | Urology Research and Practice |
| Gaiak: | |
| Sarrera elektronikoa: | http://urologyresearchandpractice.org/index.php/pub/article/view/2776 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|